Home » Newsletters » BioWorld Science

BioWorld Science

June 4, 2014

View Archived Issues

Early clinical results presented for lentiviral-based anti-HIV therapeutic vaccine

New association of an Alzheimer's-associated polymorphism with major depressive disorder

Pharmacological profile of bifunctional MABAs presented at ATS meeting

New data on lead tetracycline antibiotic presented by Tetraphase

Teriparatide evidences potential for spinal fusion and fractures

Roche patent divulges novel K(Ca)3.1 channel blockers

Cephalon researchers prepare and test bendamustine prodrugs

Ohio State University reports development of gemcitabine analogues

Preliminary findings reported for anti-CD37 ADC in patients with NHL

MSD plans phase III trial of MK-8228 to prevent CMV infection in HSCT recipients

Trevi plans phase II studies of nalbuphine ER in uremic pruritus

Asterias Biotherapeutics receives grant for trial of stem cell therapy in spinal cord injury

Innate Pharma and Enzo Biochem validate ProteoStat for ADC stability testing

QIAGEN and Lilly collaborate on DNA and RNA diagnostic for cancer

Spanish researchers prepare new prolyl endopeptidase inhibitors

Agios Pharmaceuticals discloses new PKLR and/or PKM activators

Novel PI3Kdelta inhibitor demonstrates clinical efficacy for hematologic malignancies

Adaptimmune and GSK establish cancer immunotherapy collaboration

MediWound expands distribution of NexoBrid to South Korea

Sequenom bioscience business acquired by Agena Bioscience

Award to support trial of Sangamo's ZFP therapeutic for HIV/AIDS

The FDA grants orphan drug status to PF-02545920 for Huntington's disease

Health Canada accepts Ravicti NDS for priority review

EMA accepts Hetlioz MAA for review

ChemoCentryx's CCX-168 receives U.S. orphan drug status for ANCA-associated vasculitis

Invega approved in E.U. for schizophrenia in adolescents

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026